EICHOR
● Completed
Baroreflex Activation Therapy for Heart Failure
Condition: Heart Failure · Sponsor: CVRx, Inc.
About this study
The purpose of this clinical trial (NCT02627196) is to develop valid scientific evidence for safety and effectiveness of Baroreflex Activation Therapy with the BAROSTIM NEO System in subjects with heart failure, defined as New York Heart Association (NYHA) functional Class III, left ventricular ejection fraction (LVEF) ≤ 35% and NT-proBNP\<1600 pg/ml despite being treated with the appropriate heart failure guideline directed therapy, excluding subjects eligible for or actively receiving Cardiac Resynchronization Therapy (CRT). The total trial duration is anticipated to be approximately 5 years; however, the duration of an individual subject enrollment will depend on when he or she entered the trial.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (92)
| Heart and Rhythm Solutions, PLLC | Chandler, Arizona, United States | — |
| Chan Heart Rhythm Institute | Mesa, Arizona, United States | — |
| Arizona Arrhythmia Research Center | Phoenix, Arizona, United States | — |
| Phoenix Cardiovascular Research Group | Phoenix, Arizona, United States | — |
| Cardiovascular Consultants, Ltd. | Phoenix, Arizona, United States | — |
| Washington Regional Medical Center | Fayetteville, Arkansas, United States | — |
| Central Cardiology Medical Center | Bakersfield, California, United States | — |
| Chula Vista Cardiac Center | Chula Vista, California, United States | — |
| Sharp Grossmont | Chula Vista, California, United States | — |
| Sharp Chula Vista Medical Center | Chula Vista, California, United States | — |
| John Muir Health Clinical Research Center | Concord, California, United States | — |
| University of California, San Francisco - Fresno | Fresno, California, United States | — |
+ 80 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.